{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:16:02Z","timestamp":1791137762136,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T00:00:00Z","timestamp":1393286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s12640-014-9458-z","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T16:39:35Z","timestamp":1393259975000},"page":"130-151","source":"Crossref","is-referenced-by-count":25,"title":["Rosiglitazone Synergizes the Neuroprotective Effects of Valproic Acid Against Quinolinic Acid-Induced Neurotoxicity in Rats: Targeting PPAR\u03b3 and HDAC Pathways"],"prefix":"10.1007","volume":"26","author":[{"given":"Jitendriya","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,25]]},"reference":[{"issue":"2","key":"9458_CR1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jep.2012.10.063","volume":"145","author":"I Baitharu","year":"2013","unstructured":"Baitharu I, Jain V, Deep SN, Hota KB, Hota SK, Prasad D, Ilavazhagan G (2013) Withania somnifera root extract ameliorates hypobaric hypoxia induced memory impairment in rats. J Ethnopharmacol 145(2):431\u2013441","journal-title":"J Ethnopharmacol"},{"issue":"17","key":"9458_CR2","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","volume":"24","author":"ZC Baquet","year":"2004","unstructured":"Baquet ZC, Gorski JA, Jones KR (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24(17):4250\u20134258","journal-title":"J Neurosci"},{"issue":"3","key":"9458_CR3","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","volume":"73","author":"SB Berman","year":"1999","unstructured":"Berman SB, Hastings TG (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson\u2019s disease. J Neurochem 73(3):1127\u20131137","journal-title":"J Neurochem"},{"key":"9458_CR4","doi-asserted-by":"crossref","first-page":"864140","DOI":"10.1155\/2008\/864140","volume":"2008","author":"A Bernardo","year":"2008","unstructured":"Bernardo A, Minghetti L (2008) Regulation of glial cell functions by PPAR-gamma natural and synthetic agonists. PPAR Res 2008:864140","journal-title":"PPAR Res"},{"issue":"2","key":"9458_CR5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0304-3940(93)90752-7","volume":"149","author":"F Block","year":"1993","unstructured":"Block F, Kunkel M, Schwarz M (1993) Quinolinic acid lesion of the striatum induces impairment in spatial learning and motor performance in rats. Neurosci Lett 149(2):126\u2013128","journal-title":"Neurosci Lett"},{"key":"9458_CR6","doi-asserted-by":"crossref","first-page":"689181","DOI":"10.4061\/2011\/689181","volume":"2011","author":"AR Carta","year":"2011","unstructured":"Carta AR, Pisanu A, Carboni E (2011) Do PPAR-gamma agonists have a future in Parkinson\u2019s disease therapy? Parkinsons Dis 2011:689181","journal-title":"Parkinsons Dis"},{"issue":"1","key":"9458_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2007.06.053","volume":"149","author":"PS Chen","year":"2007","unstructured":"Chen PS, Wang CC, Bortner CD, Peng GS, Wu X, Pang H, Lu RB, Gean PW, Chuang DM, Hong JS (2007) Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 149(1):203\u2013212","journal-title":"Neuroscience"},{"issue":"1","key":"9458_CR8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.08.016","volume":"45","author":"MC Chiang","year":"2012","unstructured":"Chiang MC, Chern Y, Huang RN (2012) PPARgamma rescue of the mitochondrial dysfunction in Huntington\u2019s disease. Neurobiol Dis 45(1):322\u2013328","journal-title":"Neurobiol Dis"},{"issue":"9","key":"9458_CR9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/neu.480230915","volume":"23","author":"DW Choi","year":"1992","unstructured":"Choi DW (1992) Excitotoxic cell death. J Neurobiol 23(9):1261\u20131276","journal-title":"J Neurobiol"},{"issue":"8","key":"9458_CR10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1023\/A:1016525716209","volume":"30","author":"L Cristiano","year":"2001","unstructured":"Cristiano L, Bernardo A, Ceru MP (2001) Peroxisome proliferator-activated receptors (PPARs) and peroxisomes in rat cortical and cerebellar astrocytes. J Neurocytol 30(8):671\u2013683","journal-title":"J Neurocytol"},{"key":"9458_CR11","first-page":"1602","volume":"18","author":"CL Curtis","year":"1992","unstructured":"Curtis CL, Ross GJ III, Hyde EA, Szymanski RE, Hull JS, Dunbar GL (1992) Intrastriatal injections of quinolinic acid cause spatial learning deficits in rats. Soc Neurosci Abstr 18:1602","journal-title":"Soc Neurosci Abstr"},{"issue":"6","key":"9458_CR12","doi-asserted-by":"crossref","first-page":"e11383","DOI":"10.1371\/journal.pone.0011383","volume":"5","author":"PK Dash","year":"2010","unstructured":"Dash PK, Orsi SA, Zhang M, Grill RJ, Pati S, Zhao J, Moore AN (2010) Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS ONE 5(6):e11383","journal-title":"PLoS ONE"},{"issue":"2","key":"9458_CR13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cardiores.2007.06.027","volume":"76","author":"G Ding","year":"2007","unstructured":"Ding G, Fu M, Qin Q, Lewis W, Kim HW, Fukai T, Bacanamwo M, Chen YE, Schneider MD, Mangelsdorf DJ, Evans RM, Yang Q (2007) Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damage. Cardiovasc Res 76(2):269\u2013279","journal-title":"Cardiovasc Res"},{"issue":"2","key":"9458_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuint.2006.04.003","volume":"49","author":"PD Drew","year":"2006","unstructured":"Drew PD, Xu J, Storer PD, Chavis JA, Racke MK (2006) Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders. Neurochem Int 49(2):183\u2013189","journal-title":"Neurochem Int"},{"issue":"1","key":"9458_CR15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82(1):70\u201377","journal-title":"Arch Biochem Biophys"},{"key":"9458_CR16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"9458_CR17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbrc.2008.12.071","volume":"379","author":"L Escribano","year":"2009","unstructured":"Escribano L, Simon AM, Perez-Mediavilla A, Salazar-Colocho P, Del Rio J, Frechilla D (2009) Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer\u2019s disease mouse model. Biochem Biophys Res Commun 379(2):406\u2013410","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"9458_CR18","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/npp.2010.32","volume":"35","author":"L Escribano","year":"2010","unstructured":"Escribano L, Simon AM, Gimeno E, Cuadrado-Tejedor M, de Maturana RL, Garcia-Osta A, Ricobaraza A, Perez-Mediavilla A, Del Rio J, Frechilla D (2010) Rosiglitazone rescues memory impairment in Alzheimer\u2019s transgenic mice: mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology 35(7):1593\u20131604","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"9458_CR19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/exnr.1993.1006","volume":"119","author":"RJ Ferrante","year":"1993","unstructured":"Ferrante RJ, Kowall NW, Cipolloni PB, Storey E, Beal MF (1993) Excitotoxin lesions in primates as a model for Huntington\u2019s disease: histopathologic and neurochemical characterization. Exp Neurol 119(1):46\u201371","journal-title":"Exp Neurol"},{"issue":"28","key":"9458_CR20","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","volume":"23","author":"RJ Ferrante","year":"2003","unstructured":"Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, Smith K, Kowall NW, Ratan RR, Luthi-Carter R, Hersch SM (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice. J Neurosci Methods 23(28):9418\u20139427","journal-title":"J Neurosci Methods"},{"issue":"1\u20132","key":"9458_CR21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","volume":"866","author":"I Ferrer","year":"2000","unstructured":"Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res 866(1\u20132):257\u2013261","journal-title":"Brain Res"},{"issue":"1","key":"9458_CR22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/exnr.1996.0054","volume":"138","author":"JC Furtado","year":"1996","unstructured":"Furtado JC, Mazurek MF (1996) Behavioral characterization of quinolinate-induced lesions of the medial striatum: relevance for Huntington\u2019s disease. Exp Neurol 138(1):158\u2013168","journal-title":"Exp Neurol"},{"issue":"4","key":"9458_CR23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neures.2006.05.003","volume":"55","author":"M Ganzella","year":"2006","unstructured":"Ganzella M, Jardim FM, Boeck CR, Vendite D (2006) Time course of oxidative events in the hippocampus following intracerebroventricular infusion of quinolinic acid in mice. Neurosci Res 55(4):397\u2013402","journal-title":"Neurosci Res"},{"issue":"10\u201311","key":"9458_CR24","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00702-004-0201-4","volume":"111","author":"G Gardian","year":"2004","unstructured":"Gardian G, Vecsei L (2004) Huntington\u2019s disease: pathomechanism and therapeutic perspectives. J Neural Transm 111(10\u201311):1485\u20131494","journal-title":"J Neural Transm"},{"issue":"4","key":"9458_CR25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10787-010-0068-y","volume":"19","author":"V Gaur","year":"2011","unstructured":"Gaur V, Kumar A (2011) Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction. Inflammopharmacology 19(4):205\u2013214","journal-title":"Inflammopharmacology"},{"issue":"1","key":"9458_CR26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP, De Mey J, MacDonald ME, Lessmann V, Humbert S, Saudou F (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118(1):127\u2013138","journal-title":"Cell"},{"issue":"2","key":"9458_CR27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","volume":"177","author":"AG Gornall","year":"1949","unstructured":"Gornall AG, Bardawill CJ, David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177(2):751\u2013766","journal-title":"J Biol Chem"},{"issue":"1","key":"9458_CR28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126(1):131\u2013138","journal-title":"Anal Biochem"},{"issue":"4","key":"9458_CR29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.0022-3042.2001.00728.x","volume":"80","author":"R Hashimoto","year":"2002","unstructured":"Hashimoto R, Hough C, Nakazawa T, Yamamoto T, Chuang DM (2002) Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J Neurochem 80(4):589\u2013597","journal-title":"J Neurochem"},{"issue":"9","key":"9458_CR30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ncpneuro0586","volume":"3","author":"MT Heneka","year":"2007","unstructured":"Heneka MT, Landreth GE, Hull M (2007) Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders. Nat Clin Pract Neurol 3(9):496\u2013504","journal-title":"Nat Clin Pract Neurol"},{"issue":"4","key":"9458_CR31","doi-asserted-by":"crossref","first-page":"C899","DOI":"10.1152\/ajpcell.00474.2004","volume":"288","author":"J Hwang","year":"2005","unstructured":"Hwang J, Kleinhenz DJ, Lassegue B, Griendling KK, Dikalov S, Hart CM (2005) Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 288(4):C899\u2013C905","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1\u20133","key":"9458_CR32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-5793(03)00350-8","volume":"542","author":"MR Jeong","year":"2003","unstructured":"Jeong MR, Hashimoto R, Senatorov VV, Fujimaki K, Ren M, Lee MS, Chuang DM (2003) Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett 542(1\u20133):74\u201378","journal-title":"FEBS Lett"},{"issue":"12","key":"9458_CR33","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1093\/hmg\/ddt098","volume":"22","author":"M Jiang","year":"2013","unstructured":"Jiang M, Peng Q, Liu X, Jin J, Hou Z, Zhang J, Mori S, Ross CA, Ye K, Duan W (2013) Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington\u2019s disease. Hum Mol Genet 22(12):2462\u20132470","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9458_CR34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/jnc.12190","volume":"125","author":"J Jin","year":"2013","unstructured":"Jin J, Albertz J, Guo Z, Peng Q, Rudow G, Troncoso JC, Ross CA, Duan W (2013) Neuroprotective effects of PPAR-\u03b3 agonist rosiglitazone in N171-82Q mouse model of Huntington\u2019s disease. J Neurochem 125(3):410\u2013419","journal-title":"J Neurochem"},{"issue":"4","key":"9458_CR35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10787-009-0012-1","volume":"17","author":"H Kalonia","year":"2009","unstructured":"Kalonia H, Kumar P, Kumar A, Nehru B (2009) Effect of caffeic acid and rofecoxib and their combination against intrastriatal quinolinic acid induced oxidative damage, mitochondrial and histological alterations in rats. Inflammopharmacology 17(4):211\u2013219","journal-title":"Inflammopharmacology"},{"issue":"2","key":"9458_CR36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbb.2010.04.018","volume":"96","author":"H Kalonia","year":"2010","unstructured":"Kalonia H, Kumar P, Kumar A (2010a) Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-\u03b3 (PPAR\u03b3) in Huntington\u2019s disease. Pharmacol Biochem Behav 96(2):115\u2013124","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"9458_CR37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.neuroscience.2010.08.039","volume":"171","author":"H Kalonia","year":"2010","unstructured":"Kalonia H, Kumar P, Kumar A, Nehru B (2010b) Protective effect of montelukast against quinolinic acid\/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-\u03b1 level alterations in rats. Neuroscience 171(1):284\u2013299","journal-title":"Neuroscience"},{"key":"9458_CR38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainres.2010.11.060","volume":"1372","author":"H Kalonia","year":"2011","unstructured":"Kalonia H, Kumar P, Kumar A (2011) Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats. Brain Res 1372:115\u2013126","journal-title":"Brain Res"},{"issue":"4","key":"9458_CR39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12640-012-9315-x","volume":"22","author":"H Kalonia","year":"2012","unstructured":"Kalonia H, Mishra J, Kumar A (2012) Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington\u2019s disease-like symptoms in rats. Neurotox Res 22(4):310\u2013320","journal-title":"Neurotox Res"},{"issue":"2","key":"9458_CR40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2004.10.007","volume":"191","author":"M Kiaei","year":"2005","unstructured":"Kiaei M, Kipiani K, Chen J, Calingasan NY, Beal MF (2005) Peroxisome proliferator\u2013activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol 191(2):331\u2013336","journal-title":"Exp Neurol"},{"issue":"5","key":"9458_CR41","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuropharm.2004.12.013","volume":"48","author":"J-H Kim","year":"2005","unstructured":"Kim J-H, Kim S, Yoon I-S, Lee J-H, Jang B-J, Jeong SM, Lee J-H, Lee B-H, Han J-S, Oh S, Kim H-C, Park TK, Rhim H, Nah S-Y (2005) Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats. Neuropharmacology 48(5):743\u2013756","journal-title":"Neuropharmacology"},{"issue":"3","key":"9458_CR42","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.107.120188","volume":"321","author":"HJ Kim","year":"2007","unstructured":"Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM (2007) Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 321(3):892\u2013901","journal-title":"J Pharmacol Exp Ther"},{"key":"9458_CR43","first-page":"322","volume-title":"Methods in enzymology","author":"TE King","year":"1967","unstructured":"King TE (1967) Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. In: Estabrook RW, Pullman ME (eds) Methods in enzymology, vol 10. Academic Press, New York, pp 322\u2013331"},{"key":"9458_CR44","first-page":"275","volume-title":"Methods in enzymololgy","author":"TE King","year":"1967","unstructured":"King TE, Howard RL (1967) Preparations and properties of soluble NADH dehydrogenases from cardiac muscle. In: Estabrook RW, Pullman ME (eds) Methods in enzymololgy, vol 10. Academic Press, New York, pp 275\u2013294"},{"issue":"1","key":"9458_CR45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","volume":"186","author":"Y Kono","year":"1978","unstructured":"Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Archiv Biochem Biophy 186(1):189\u2013195","journal-title":"Archiv Biochem Biophy"},{"issue":"6","key":"9458_CR46","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.RES.59.6.612","volume":"59","author":"RC Kukreja","year":"1986","unstructured":"Kukreja RC, Kontos HA, Hess ML, Ellis EF (1986) PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res 59(6):612\u2013619","journal-title":"Circ Res"},{"issue":"1","key":"9458_CR47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pbb.2012.07.015","volume":"103","author":"A Kumar","year":"2012","unstructured":"Kumar A, Prakash A, Pahwa D, Mishra J (2012a) Montelukast potentiates the protective effect of rofecoxib against kainic acid-induced cognitive dysfunction in rats. Pharmacol Biochem Behav 103(1):43\u201352","journal-title":"Pharmacol Biochem Behav"},{"key":"9458_CR48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2012.06.050","volume":"1471","author":"A Kumar","year":"2012","unstructured":"Kumar A, Sharma N, Gupta A, Kalonia H, Mishra J (2012b) Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms. Brain Res 1471:13\u201322","journal-title":"Brain Res"},{"issue":"1\u20133","key":"9458_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.03.042","volume":"709","author":"A Kumar","year":"2013","unstructured":"Kumar A, Sharma N, Mishra J, Kalonia H (2013) Synergistical neuroprotection of rofecoxib and statins against malonic acid induced Huntington\u2019s disease like symptoms and related cognitive dysfunction in rats. Eur J Pharmacol 709(1\u20133):1\u201312","journal-title":"Eur J Pharmacol"},{"issue":"9251","key":"9458_CR50","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(00)03600-X","volume":"357","author":"P Kwan","year":"2001","unstructured":"Kwan P, Brodie MJ (2001) Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 357(9251):216\u2013222","journal-title":"Lancet"},{"issue":"1","key":"9458_CR51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(01)01423-6","volume":"431","author":"A Lampen","year":"2001","unstructured":"Lampen A, Carlberg C, Nau H (2001) Peroxisome proliferator-activated receptor delta is a specific sensor for teratogenic valproic acid derivatives. Eur J Pharmacol 431(1):25\u201333","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"9458_CR52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1568007053005091","volume":"4","author":"B Langley","year":"2005","unstructured":"Langley B, Gensert JM, Beal MF, Ratan RR (2005) Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr Drug Targets CNS Neurol Disord 4(1):41\u201350","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"3","key":"9458_CR53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.toxlet.2012.07.016","volume":"213","author":"EY Lee","year":"2012","unstructured":"Lee EY, Lee JE, Park JH, Shin IC, Koh HC (2012) Rosiglitazone, a PPAR-gamma agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats. Toxicol Lett 213(3):332\u2013344","journal-title":"Toxicol Lett"},{"issue":"2","key":"9458_CR54","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1471-4159.1997.69020581.x","volume":"69","author":"Y Liu","year":"1997","unstructured":"Liu Y, Peterson DA, Kimura H, Schubert D (1997) Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 69(2):581\u2013593","journal-title":"J Neurochem"},{"key":"9458_CR55","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/B978-0-12-395630-9.50158-4","volume-title":"Methods of enzymatic analysis","author":"H Luck","year":"1965","unstructured":"Luck H (1965) Catalase. In: Hans UB (ed) Methods of enzymatic analysis, 2nd edn. Academic Press, New York, pp 885\u2013894","edition":"2"},{"key":"9458_CR56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0197-4580(94)00150-2","volume":"16","author":"RJ Mark","year":"1995","unstructured":"Mark RJ, Ashford JW, Goodman Y, Mattson MP (1995) Anticonvulsants attenuate amyloid beta-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology. Neurobiol Aging 16:187\u2013198","journal-title":"Neurobiol Aging"},{"issue":"4","key":"9458_CR57","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG (2008) Glial reactions in Parkinson\u2019s disease. Mov Disord 23(4):474\u2013483","journal-title":"Mov Disord"},{"issue":"1","key":"9458_CR58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11(1):47\u201360","journal-title":"J Neurosci Methods"},{"key":"9458_CR59","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.106.113472","volume":"320","author":"SW Park","year":"2007","unstructured":"Park SW, Yi JH, Miranpuri G, Satriotomo I, Bowen K, Resnick DK, Vemuganti R (2007) Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J Pharmacol Exp Ther 320:1002\u20131012","journal-title":"J Pharmacol Exp Ther"},{"key":"9458_CR60","unstructured":"Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. Academic Press, San Diego"},{"key":"9458_CR61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2006.01.018","volume":"199","author":"WA Pedersen","year":"2006","unstructured":"Pedersen WA, McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, Haynatzki GR (2006) Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol 199:265\u2013273","journal-title":"Exp Neurol"},{"key":"9458_CR62","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/jir.1997.17.589","volume":"17","author":"LA Pemberton","year":"1997","unstructured":"Pemberton LA, Kerr SJ, Smythe G, Brew BJ (1997) Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha. J Interf Cytokine Res 17:589\u2013595","journal-title":"J Interf Cytokine Res"},{"issue":"1","key":"9458_CR63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molbrainres.2004.10.021","volume":"134","author":"GS Peng","year":"2005","unstructured":"Peng GS, Li G, Tzeng NS, Chen PS, Chuang DM, Hsu YD, Yang S, Hong JS (2005) Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia. Brain Res 134(1):162\u2013169","journal-title":"Brain Res"},{"key":"9458_CR64","first-page":"1","volume":"5","author":"V Perez-De La Cruz","year":"2012","unstructured":"Perez-De La Cruz V, Carrillo-Mora P, Santamaria A (2012) Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms. Int J Tryptophan Res 5:1\u20138","journal-title":"Int J Tryptophan Res"},{"key":"9458_CR65","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734\u201336741","journal-title":"J Biol Chem"},{"key":"9458_CR66","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neuroscience.2007.05.033","volume":"148","author":"B Poeggeler","year":"2007","unstructured":"Poeggeler B, Rassoulpour A, Wu HQ, Guidetti P, Roberts RC, Schwarcz R (2007) Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-d-aspartate neurotoxicity. Neuroscience 148:188\u2013197","journal-title":"Neuroscience"},{"key":"9458_CR67","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0006-2952(91)90557-L","volume":"41","author":"S Ponchaut","year":"1991","unstructured":"Ponchaut S, Draye JP, Veitch K, Van Hoof F (1991) Influence of chronic administration of valproate on ultrastructure and enzyme content of peroxisomes in rat liver and kidney. Oxidation of valproate by liver peroxisomes. Biochem Pharmacol 41:1419\u20131428","journal-title":"Biochem Pharmacol"},{"key":"9458_CR68","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1074\/jbc.M804291200","volume":"283","author":"RA Quintanilla","year":"2008","unstructured":"Quintanilla RA, Jin YN, Fuenzalida K, Bronfman M, Johnson GV (2008) Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease. J Biol Chem 283:25628\u201325637","journal-title":"J Biol Chem"},{"key":"9458_CR69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainres.2012.07.026","volume":"1473","author":"A Reiner","year":"2012","unstructured":"Reiner A, Wang HB, Del Mar N, Sakata K, Yoo W, Deng YP (2012) BDNF may play a differential role in the protective effect of the mGluR2\/3 agonist LY379268 on striatal projection neurons in R6\/2 Huntington\u2019s disease mice. Brain Res 1473:161\u2013172","journal-title":"Brain Res"},{"key":"9458_CR70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(01)02504-6","volume":"318","author":"JI Rossato","year":"2002","unstructured":"Rossato JI, Zeni G, Mello CF, Rubin MA, Rocha JB (2002) Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat. Neurosci Lett 318:137\u2013140","journal-title":"Neurosci Lett"},{"issue":"4","key":"9458_CR71","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/156720506778249407","volume":"3","author":"G Sadri-Vakili","year":"2006","unstructured":"Sadri-Vakili G, Cha JH (2006) Histone deacetylase inhibitors: a novel therapeutic approach to Huntington\u2019s disease (complex mechanism of neuronal death). Curr Alzheimer Res 3(4):403\u2013408","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"9458_CR72","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1601-183X.2012.00858.x","volume":"12","author":"P Samadi","year":"2013","unstructured":"Samadi P, Boutet A, Rymar VV, Rawal K, Maheux J, Kvann JC, Tomaszewski M, Beaubien F, Cloutier JF, Levesque D, Sadikot AF (2013) Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6\/2 mouse model of Huntington\u2019s disease. Genes Brain Behav 12(1):108\u2013124","journal-title":"Genes Brain Behav"},{"issue":"1","key":"9458_CR73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-4886(89)90170-2","volume":"105","author":"PR Sanberg","year":"1989","unstructured":"Sanberg PR, Calderon SF, Giordano M, Tew JM, Norman AB (1989) The quinolinic acid model of Huntington\u2019s disease: locomotor abnormalities. Exp Neurol 105(1):45\u201353","journal-title":"Exp Neurol"},{"issue":"1\u20132","key":"9458_CR74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3940(93)90796-N","volume":"159","author":"A Santamaria","year":"1993","unstructured":"Santamaria A, Rios C (1993) MK-801, an N-methyl-d-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum. Neurosci Lett 159(1\u20132):51\u201354","journal-title":"Neurosci Lett"},{"issue":"4582","key":"9458_CR75","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","volume":"219","author":"R Schwarcz","year":"1983","unstructured":"Schwarcz R, Whetsell WO Jr, Mangano RM (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219(4582):316\u2013318","journal-title":"Science"},{"issue":"2","key":"9458_CR76","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","volume":"90","author":"R Schwarcz","year":"2010","unstructured":"Schwarcz R, Guidetti P, Sathyasaikumar KV, Muchowski PJ (2010) Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington\u2019s disease. Prog Neurobiol 90(2):230\u2013245","journal-title":"Prog Neurobiol"},{"issue":"7","key":"9458_CR77","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0278-5846(98)00070-0","volume":"22","author":"DA Shear","year":"1998","unstructured":"Shear DA, Dong J, Gundy CD, Haik-Creguer KL, Dunbar GL (1998) Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington\u2019s disease. Prog Neuro-psychopharmacol Biol Psychiatry 22(7):1217\u20131240","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"2","key":"9458_CR78","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2005.08.001","volume":"21","author":"J Shehadeh","year":"2006","unstructured":"Shehadeh J, Fernandes HB, Mullins MMZ, Graham RK, Leavitt BR, Hayden MR, Raymond LA (2006) Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease. Neurobiol Dis 21(2):392\u2013403","journal-title":"Neurobiol Dis"},{"key":"9458_CR79","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0306-4522(96)00326-0","volume":"75","author":"NA Simonian","year":"1996","unstructured":"Simonian NA, Getz RL, Leveque JC, Konradi C, Coyle JT (1996) Kainic acid induces apoptosis in neurons. Neuroscience 75:1047\u20131055","journal-title":"Neuroscience"},{"key":"9458_CR80","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1083\/jcb.32.2.415","volume":"32","author":"GL Sottocasa","year":"1967","unstructured":"Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A (1967) An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol 32:415\u2013438","journal-title":"J Cell Biol"},{"issue":"1","key":"9458_CR81","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0091-3057(95)00059-6","volume":"52","author":"S Sudha","year":"1995","unstructured":"Sudha S, Lakshmana MK, Pradhan N (1995) Chronic phenytoin induced impairment of learning and memory with associated changes in brain acetylcholine esterase activity and monoamine levels. Pharmacol Biochem Behav 52(1):119\u2013124","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20133","key":"9458_CR82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.03.024","volume":"537","author":"M Tuzcu","year":"2006","unstructured":"Tuzcu M, Baydas G (2006) Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats. Eur J Pharmacol 537(1\u20133):106\u2013110","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"9458_CR83","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jpsychires.2010.02.009","volume":"44","author":"SS Valvassori","year":"2010","unstructured":"Valvassori SS, Rezin GT, Ferreira CL, Moretti M, Goncalves CL, Cardoso MR, Streck EL, Kapczinski F, Quevedo J (2010) Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. J Psychiatr Res 44(14):903\u2013909","journal-title":"J Psychiatr Res"},{"issue":"12","key":"9458_CR84","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/0006-2952(85)90409-5","volume":"34","author":"C Branden Van den","year":"1985","unstructured":"Van den Branden C, Roels F (1985) Peroxisomal beta-oxidation and sodium valproate. Biochem Pharmacol 34(12):2147\u20132149","journal-title":"Biochem Pharmacol"},{"key":"9458_CR85","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/jnr.22710","volume":"89","author":"R Verma","year":"2011","unstructured":"Verma R, Mishra V, Gupta K, Sasmal D, Raghubir R (2011) Neuroprotection by rosiglitazone in transient focal cerebral ischemia might not be mediated by glutamate transporter-1. J Neurosci Res 89:1849\u20131858","journal-title":"J Neurosci Res"},{"issue":"3","key":"9458_CR86","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1601-183X.2012.00764.x","volume":"11","author":"L Wang","year":"2012","unstructured":"Wang L, Ashley-Koch A, Steffens DC, Krishnan KR, Taylor WD (2012) Impact of BDNF Val66Met and 5-HTTLPR polymorphism variants on neural substrates related to sadness and executive function. Genes Brain Behav 11(3):352\u2013359","journal-title":"Genes Brain Behav"},{"issue":"3","key":"9458_CR87","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","volume":"99","author":"ED Wills","year":"1966","unstructured":"Wills ED (1966) Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99(3):667\u2013676","journal-title":"Biochem J"},{"issue":"3","key":"9458_CR88","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1471-4159.2011.07316.x","volume":"118","author":"Y Yang","year":"2011","unstructured":"Yang Y, Qin X, Liu S, Li J, Zhu X, Gao T, Wang X (2011) Peroxisome proliferator-activated receptor \u03b3 is inhibited by histone deacetylase 4 in cortical neurons under oxidative stress. J Neurochem 118(3):429\u2013439","journal-title":"J Neurochem"},{"issue":"1","key":"9458_CR89","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbb.2009.08.001","volume":"94","author":"D Zadori","year":"2009","unstructured":"Zadori D, Geisz A, Vamos E, Vecsei L, Klivenyi P (2009) Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington\u2019s disease. Pharmacol Biochem Behav 94(1):148\u2013153","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"9458_CR90","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0021-9258(19)81724-6","volume":"243","author":"WL Zahler","year":"1968","unstructured":"Zahler WL, Cleland WW (1968) A specific and sensitive assay for disulfides. J Biol Chem 243(4):716\u2013719","journal-title":"J Biol Chem"},{"issue":"5\u20136","key":"9458_CR91","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol 81(5\u20136):294\u2013330","journal-title":"Prog Neurobiol"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-014-9458-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-014-9458-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-014-9458-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T14:36:27Z","timestamp":1648391787000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-014-9458-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,25]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["9458"],"URL":"https:\/\/doi.org\/10.1007\/s12640-014-9458-z","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,25]]}}}